AFF3 is a Prognostic Biomarker Correlated with Immune Infiltrates in Triple-Negative Breast Cancer
Background: Triple-negative breast cancer (TNBC) is an aggressive type of breast cancer that cannot be treated with targeted therapies such as endocrine therapy or anti-HER-2 (anti-human epidermal growth factor receptor 2) therapy. In the growth of tumors, AFF3 (AF4/FMR2 family member 3) plays a cri...
Збережено в:
| Автори: | , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
IMR Press
2023-08-01
|
| Серія: | Clinical and Experimental Obstetrics & Gynecology |
| Предмети: | |
| Онлайн доступ: | https://www.imrpress.com/journal/CEOG/50/8/10.31083/j.ceog5008165 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|